[Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
D000319:Adrenergic beta-Antagonists / Q000502:physiology* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000375:Aging; D000804:Angiotensin II / Q000378:metabolism* / Q000502:physiology; D002395:Catecholamines / Q000502:physiology; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D010096:Oxprenolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012083:Renin / Q000378:metabolism* / Q000502:physiology; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D004232:Diuretics; D014665:Vasodilator Agents; D000804:Angiotensin II; D010096:Oxprenolol; D011433:Propranolol; D012083:Renin
Essentielle Hypertonie: adrenerges Kontroll-system, Renin-Angiotensin-Effektorachse, Niere und Alter